Case Report
Accepted on 29 Jan 2026
Co-existence of BCR::PDGFRA gene fusion and PDGFRA variants in myeloid neoplasm with persistent leukocytosis, large splenomegaly, and eosinophilia
in Hematologic Malignancies
Frontiers in Oncology
Type at least 3 characters
2,041 articles
articles
Case Report
Published on 29 Jan 2026
Syndrome of inappropriate antidiuresis secondary to multiple myeloma: a case report and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1697444
- 253 views
Case Report
Accepted on 28 Jan 2026
Acute Promyelocytic Leukemia with Novel TTMV::RARA Fusion Initially Presenting as Vertebral Myeloid Sarcoma: A Case Report
in Hematologic Malignancies
Frontiers in Oncology
Original Research
Published on 28 Jan 2026
Bcl-2 inhibitor resistance in diffuse large b-cell lymphoma: establishing a prognostic signature and targeting alpha protein kinase 1
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1729158
- 467 views
Case Report
Published on 28 Jan 2026
Case Report: Simultaneous chronic lymphocytic leukemia and macrofocal multiple myeloma with extramedullary plasmacytoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1747723
- 306 views
Original Research
Published on 28 Jan 2026
Safety and feasibility assessment of implantable chest wall venous access port for patients with acute leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1749957
- 267 views
Original Research
Accepted on 26 Jan 2026
MULTIPLE MYELOMA IN THE REAL WORLD SETTINGS: PROGNOSTIC SIGNIFICANCE OF 1q21 CHROMOSOMAL ABNORMALITIES - SINGLE CENTER EXPERIENCE
in Hematologic Malignancies
Frontiers in Oncology
- 110 views
Original Research
Accepted on 26 Jan 2026
Siltuximab as a First-Line Therapy for Idiopathic Multicentric Castleman Disease: A Retrospective Analysis Based on the SiMuLa study of the Italian regional network
in Hematologic Malignancies
Frontiers in Oncology
- 113 views
Case Report
Accepted on 26 Jan 2026
Richter Transformation to Classical Hodgkin Lymphoma Following Recurrent Disseminated Histoplasmosis in Chronic Lymphocytic Leukemia: A Case Report
in Hematologic Malignancies
Frontiers in Oncology
- 113 views
Review
Accepted on 26 Jan 2026
TP53-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Comprehensive Overview of Targeted Approaches
in Hematologic Malignancies
Frontiers in Oncology
Case Report
Accepted on 26 Jan 2026
A rare case report of Relapsed/Refractory Primary cutaneous diffuse large B-cell lymphoma, leg type, treated with Epcoritamab: Results obtained and lesson learned
in Hematologic Malignancies
Frontiers in Oncology
Case Report
Published on 26 Jan 2026
Case report: A case of mast cell leukemia treated with avapritinib: from diagnostic challenge to transplantation
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1746589
- 375 views
Original Research
Published on 26 Jan 2026
Predicting modelling for early diagnosis in early myeloproliferative neoplasms, not otherwise specified. Evidence from a machine learning study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1741610
- 410 views
Case Report
Accepted on 23 Jan 2026
Acute hemiplegia as initial presentation in FIP1L1-PDGFRA-rearranged myeloid neoplasm with eosinophilia: a case report
in Hematologic Malignancies
Frontiers in Oncology
- 134 views
Case Report
Published on 22 Jan 2026
Acute lymphoblastic leukemia with bone marrow necrosis as the first clinical manifestation: a pediatric case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1737632
- 435 views
Brief Research Report
Published on 22 Jan 2026
Efficacy and tolerability of mogamulizumab in mycosis fungoides and Sézary Syndrome: a monocentric retrospective study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1748746
- 448 views
Original Research
Published on 21 Jan 2026
Regional, demographic and temporal trends in anemia and malignant cancer-related mortality in U.S. older adults: a nationwide CDC WONDER analysis (1999–2020)
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1722891
- 686 views
Original Research
Accepted on 20 Jan 2026
Addressing unmet needs in relapsed/refractory multiple myeloma: an Italian Delphi consensus on current challenges and emerging therapies
in Hematologic Malignancies
Frontiers in Oncology
- 155 views
Original Research
Accepted on 20 Jan 2026
Association between the Prognostic Nutritional Index and Early Mortality of AML Patients after Allogeneic HSCT: A Retrospective Cohort Analysis
in Hematologic Malignancies
Frontiers in Oncology
- 100 views
Original Research
Accepted on 20 Jan 2026
Analysis of Risk Factors for PICC-related Venous Thrombosis in Patients with Hematological Malignancies and Establishment of a Nomogram Prediction Model
in Hematologic Malignancies
Frontiers in Oncology
Case Report
Published on 20 Jan 2026
Case Report: CD19 CAR-T therapy induces durable remission in a pediatric patient with TP53-mutated, refractory Burkitt lymphoma: a 30-month follow-up
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1702660
- 418 views
Review
Published on 20 Jan 2026
Efficacy and safety of BTK inhibitors in Richter’s transformation: a systematic review of clinical evidence
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1681589
- 538 views
Mini Review
Published on 20 Jan 2026
NCOA4 and ferritinophagy in hematological malignancies: a double-edged regulator of iron metabolism and cell fate
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1717435
- 387 views
Review
Accepted on 19 Jan 2026
The Role of Epigenetic Modifications in Hematological Cancers
in Hematologic Malignancies
Frontiers in Oncology
- 107 views